Melissa A Cadnapaphornchai

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Polycystic Kidney Disease

Duchenne Muscular Dystrophy

Top Venues

Pediatric nephrology (Berlin, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Djalila Mekahli, Max Christoph Liebau, Melissa A Cadnapaphornchai, Stuart L Goldstein, Larry A Greenbaum, Mieczyslaw Litwin, Tomas Seeman, Franz Schaefer, Lisa M Guay-Woodford
Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease. BMC nephrology 24 (1) (2023)
Djalila Mekahli, Max Christoph Liebau, Melissa A Cadnapaphornchai, Stuart L Goldstein, Larry A Greenbaum, Mieczyslaw Litwin, Tomas Seeman, Franz Schaefer, Lisa M Guay-Woodford
Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease. BMC nephrology 24 (1) (2023)
Djalila Mekahli, Max Christoph Liebau, Melissa A Cadnapaphornchai, Stuart L Goldstein, Larry A Greenbaum, Mieczyslaw Litwin, Tomas Seeman, Franz Schaefer, Lisa M Guay-Woodford
Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease. BMC nephrology 24 (1) (2023)
Djalila Mekahli, Lisa M Guay-Woodford, Melissa A Cadnapaphornchai, Stuart L Goldstein, Ann Dandurand, Huan Jiang, Pravin Jadhav, Laurie Debuque
Estimating risk of rapid disease progression in pediatric patients with autosomal dominant polycystic kidney disease: a randomized trial of tolvaptan. Pediatric nephrology (Berlin, Germany) (2023)
Djalila Mekahli, Max Christoph Liebau, Melissa A Cadnapaphornchai, Stuart L Goldstein, Larry A Greenbaum, Mieczyslaw Litwin, Tomas Seeman, Franz Schaefer, Lisa M Guay-Woodford
Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease. BMC nephrology 24 (1) (2023)